Experimental Group | GFR | RPF | RBF | RVR |
---|---|---|---|---|
ml/min/300 g | mm Hg/ml/min/300 g | |||
Whole blood (n = 16) | 2.8 ± 0.1 | 8.1 ± 0.3 | 15.4 ± 0.6 | 8.0 ± 0.6 |
Sham (n = 5) | 3.2 ± 0.2 | 9.4 ± 0.5 | 17.6 ± 0.9 | 6.4 ± 0.4 |
HSA (n = 10) | 3.2 ± 0.1 | 10.5 ± 0.5* | 16.0 ± 0.8 | 6.7 ± 0.3 |
Unmodified hemoglobin solution (n = 15) | 1.8 ± 0.2a,b,c | 5.9 ± 0.5a,b,c | 9.6 ± 0.9a,b,c | 15.9 ± 1.9a,b,c |
Cross-linked hemoglobin solution 1 (n = 25) | 2.7 ± 0.13-d | 9.0 ± 0.33-d | 14.0 ± 0.5a,b,c,d | 9.2 ± 0.4b,c,d |
Cross-linked hemoglobin solution 2 (n = 10) | 3.4 ± 0.1d,e | 10.4 ± 0.5d,e | 15.8 ± 0.6d,e | 7.3 ± 0.2d,e |
Cross-linked hemoglobin solution 3 (n= 10) | 3.2 ± 0.1d,e | 10.4 ± 0.4d,e | 15.6 ± 0.6d,e | 7.6 ± 0.4d,e |
3-a p < .01 compared with rats exchange-transfused with whole blood.
3-b p < .01 compared with sham-operated rats.
3-c p < .01 compared with group exchange-transfused with HSA.
↵3-d p < .01 compared with group exchange-transfused with unmodified hemoglobin.
3-e p < .01 compared with group exchange-transfused with O-raffinose cross-linked solution 1.